2022年から取材依頼窓口はメールではなく、Discordに移行させていただきました。info宛にお送りいただいても対応ができませんのであらかじめご了承ください。また、お電話にてコンタクト ...

DeliZmart, which digitalizes the merchandising (MD) domain of the food distribution industry, announced on the 14th that it has conducted a pre-Series A funding through a third-party allotment of ...

Compliance Data Lab announced on April 8 that it has raised 200 million yen in a Series A round through a third-party allotment of shares with Nissay Capital as the lead investor, along with Quantum ...

Zip Infrastructure, which develops the self-propelled ropeway “Zippar,” announced on the 4th that it has raised additional funding in its Series A round through a third-party allotment of shares to ...

LOOV, which provides interactive personalized video services, announced on the 28th that it has raised funds through a third-party allotment of shares to Global Brain, One Capital, HAKOBUNE, and IHVC.

eve autonomy, which provides the Level 4 autonomous transport solution “eve auto” primarily for factories and logistics facilities, announced on the 12th that it has raised 1 billion yen in a Series B ...

ABABA, which develops and provides new graduate recruitment support services, announced on the 7th that it has raised 1.25 billion yen in its Series B round through a third-party allocation of shares ...

AeterLink, which develops wireless charging technology, announced on the 26th that it has raised 1.8 billion yen in a Series B extension round and 1 billion yen in venture debt, totaling 2.8 billion ...

HAKKI AFRICA, which operates microfinance business for taxi drivers in Africa, announced on the 3rd raising 1.97 billion yen in funding jointly led by SMBC Venture Capital and Global Brain. The Series ...

Innovacell, engaged in research and development of cell therapy drugs for treating fecal and urinary incontinence, announced on the 22nd that it has raised 1.06 billion yen through the equity ...

SmartBank, provider of the household management service “B/43” (Be-Yon-San), announced on the 16th the completion of a 250 million yen second close of their Series B round. The funding comes through ...

MabGenesis, a biotechnology company specializing in antibody drug development, announced on the 24th that it has raised 470 million yen (approximately $3.2 million) in its latest funding round.